Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia
- PMID: 8883573
- DOI: 10.1111/j.1600-0447.1996.tb09835.x
Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia
Abstract
The influence of sociodemographic, clinical and treatment factors on the quality of life of patients with schizophrenia has yet to be fully defined. We evaluated the quality of life of patients with schizophrenia who were attending a catchment area rehabilitation centre, in order to establish its clinical correlates. These patients had a poor to moderate quality of life which was inversely related to negative symptom severity, illness duration, the cumulative length of previous hospitalization and patient age. Patients residing in hostels or group homes had a poorer quality of life than those living independently or with their family. The presence of tardive dyskinesia was associated with a poorer quality of life. This association merits further investigation.
Similar articles
-
The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenics.Brain Cogn. 1993 Sep;23(1):28-39. doi: 10.1006/brcg.1993.1042. Brain Cogn. 1993. PMID: 8105820
-
Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness.Am J Psychiatry. 1999 Jul;156(7):1097-9. doi: 10.1176/ajp.156.7.1097. Am J Psychiatry. 1999. PMID: 10401460
-
The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders.Eur Arch Psychiatry Clin Neurosci. 2004 Dec;254(6):356-61. doi: 10.1007/s00406-004-0514-1. Epub 2004 Nov 12. Eur Arch Psychiatry Clin Neurosci. 2004. PMID: 15538607 Clinical Trial.
-
Prevalence of tardive dyskinesia in private psychiatric inpatients.Tex Med. 1989 Jan;85(1):25-8. Tex Med. 1989. PMID: 2564217 Review.
-
The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.Psychiatr Dev. 1987 Winter;5(4):301-19. Psychiatr Dev. 1987. PMID: 2895467 Review.
Cited by
-
Patients' subjective experiences of antipsychotics: clinical relevance.CNS Drugs. 2002;16(7):457-71. doi: 10.2165/00023210-200216070-00003. CNS Drugs. 2002. PMID: 12056921 Review.
-
Socio-demographic and clinical determinants of quality of life in Chinese patients with schizophrenia: a prospective study.Qual Life Res. 2010 Apr;19(3):317-22. doi: 10.1007/s11136-010-9593-9. Epub 2010 Feb 5. Qual Life Res. 2010. PMID: 20135234
-
Quality of Life and Explanatory Models of Illness in Patients with Schizophrenia.Indian J Psychol Med. 2018 Jul-Aug;40(4):328-334. doi: 10.4103/IJPSYM.IJPSYM_144_18. Indian J Psychol Med. 2018. PMID: 30093743 Free PMC article.
-
The relationship of personality dimensions as measured by the temperament and character inventory and quality of life in individuals with schizophrenia or schizoaffective disorder living in the community.Qual Life Res. 2001;10(2):133-9. doi: 10.1023/a:1016790230228. Qual Life Res. 2001. PMID: 11642683
-
A descriptive analysis of spontaneous reports of antipsychotic-induced tardive dyskinesia and other extrapyramidal symptoms in the Japanese Adverse Drug Event Report database.Neuropsychopharmacol Rep. 2024 Mar;44(1):221-226. doi: 10.1002/npr2.12385. Epub 2023 Oct 26. Neuropsychopharmacol Rep. 2024. PMID: 37884014 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical